Back

XLV Stock

Live symbol workspace

XLV market intelligence

Chart context, AI evidence, sentiment, related news, and verified outcome history are grouped into one asset dossier.

Current $146.81
Trend Flat
Sentiment Neutral

Price Chart

📈
Loading chart for XLV...
Powered by TradingView
{# Only render the live technical grid when the AI analysis carries real, non-placeholder data. Sentinel payloads (data_status error/collecting, current_price 0) are handled by the Asset Intelligence Dossier below, which degrades to a calm branded empty state instead of "0%" widgets. #}

Detailed Market Analysis

Key Levels

Support
$139.47
Resistance
$154.15

Volume & Momentum

Volume
Weak
0.8x avg
Momentum
0%
Weak

Technical Context

Current price
$146.81
RSI context
50

Market Sentiment

50
Neutral

Stock Metrics

Daily Vol
0%
VIX Est
20
Weekly
0%

Asset Intelligence Dossier

Over the last 30 days, AI sentiment for XLV skewed bullish (7 of 14 scored calls).

Provider track record

Not enough scored provider calls yet for this asset.

Confidence trend

30%
▼ 8.8 pts vs previous week
Avg confidence across 29 calls in the last 7 days

What sources say

Bullish 7 articles
3 Healthcare Stocks with Open Questions
Vanguard Health Care ETF vs State Street XLV: Which ETF Is the Better Buy for Investors in 2026?
State Street XLV vs VanEck BBH: Which Healthcare ETF Is the Better Buy in 2026?
Neutral 5 articles
Which Is the Better State Street Healthcare ETF: The Broad XLV or the Biotech XBI?
XLV vs. IBBQ: Is Broad Healthcare Exposure or Biotech Growth the Better ETF Buy?
XLV vs PBE: Is a Low-Cost Healthcare ETF the Better Buy Than a Focused Biotech Specialist?
Bearish 2 articles
State Street vs. First Trust: Is a Broad Healthcare or Biotech Focus Better for Your Portfolio?
PINK vs. XLV: How Do These Two Health Care ETFs Match Up?

Insider Trading

Refreshing insider trades from FinViz…

Technical Observations

Refreshing technical observations from FinViz...

XLV News Intelligence (32 articles)

AI-curated news influencing XLV price, sentiment, and trend

Explore All XLV News with AI Analysis
Economy
1 week, 1 day ago

3 Healthcare Stocks with Open Questions

Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited …

Impact on XLV: The healthcare sector's outperformance is likely to attract investor attention, potentially leading …
The healthcare sector has outperformed the S&P 500 by 11.2 percentage points over the past … High (70%)
View full analysis →
Yahoo Finance 70% confidence
Economy
2 weeks, 1 day ago

State Street XLV vs VanEck BBH: Which Healthcare ETF Is the Better Buy in 2026?

XLV's lower costs and broader holdings delivered 30% more growth over five years, while BBH's concentrated biotech focus offers higher …

Impact on XLV: Potentially positive price action expected
Analysis of stock market developments showing bullish sentiment. Medium (60%)
View full analysis →
Yahoo Finance 60% confidence
Economy
2 weeks, 3 days ago

Which Is the Better State Street Healthcare ETF: The Broad XLV or the Biotech XBI?

XBI surged 76% in one year but carries triple the expense ratio and far steeper downside risk. Which fund matches …

Impact on XLV: Neutral market sentiment indicated
Financial market analysis indicating neutral sentiment based on current trends. Medium (50%)
View full analysis →
Yahoo Finance 50% confidence
Economy
2 weeks, 5 days ago

XLV vs. IBBQ: Is Broad Healthcare Exposure or Biotech Growth the Better ETF Buy?

IBBQ posted the stronger return over the past year, but has also experienced much higher historical volatility than XLV.

Impact on XLV: The outperformance of IBBQ may attract investors seeking growth, potentially leading to …
The IBBQ biotech ETF has outperformed XLV over the past year but with higher volatility, … Medium (60%)
View full analysis →
Yahoo Finance 60% confidence
Economy
2 weeks, 5 days ago

XLV vs PBE: Is a Low-Cost Healthcare ETF the Better Buy Than a Focused Biotech Specialist?

PBE surged 41% in one year but endured a 35% drawdown, while XLV's diversified approach delivered steadier gains with half …

Impact on XLV: The comparison between XLV and PBE may lead to capital rotation from …
The healthcare ETF XLV has demonstrated steadier gains and lower volatility compared to the biotech … High (70%)
View full analysis →
Yahoo Finance 70% confidence
🤖

AI Analysis

Multi-Provider AI Analysis

Neutral

AI Summary

Loading...

Confidence
0%
AI Model Multi-Provider AI Analysis
Open article